Rectal 1% Tenofovir Gel Use Associates with Altered Epidermal Protein Expression

Rectal use of a 1% tenofovir (TFV) gel is currently being evaluated for HIV prevention. While careful assessment of mucosal safety of candidate microbicides is a primary concern, tools to assess mucosal toxicity are limited. Mass spectrometry-based proteomics is a sensitive and high-throughput techn...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AIDS Res Hum Retroviruses
Main Authors: Romas, Laura, Birse, Kenzie, Mayer, Kenneth H., Abou, Max, Westmacott, Garrett, Giguere, Rebecca, Febo, Irma, Cranston, Ross D., Carballo-Diéguez, Alex, McGowan, Ian, Burgener, Adam
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2016
Assuntos:
PReP
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5067863/
https://ncbi.nlm.nih.gov/pubmed/27316778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2015.0381
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados